Fluofarma will be exhibitor at the EORTC-NCI-AACR Symposium that will be held
in Berlin, Germany, 16-19 November 2010.
The symposium, ‘Molecular Targets and Cancer Therapeutics’ will bring
together academics, scientists and representatives from the pharmaceutical
industry to discuss innovation in drug development, target selection and the
impact of new discoveries in molecular and cell biology. Feel free to meet us
at our booth n°F13.
Fluofarma will be attending the Bio-Connexion Congress in Paris, from October 6th to 7th. The BIO-connexion congres will highlight the new methods of toxicity testing in drug discovery.
Fluofarma will be attending the European Cancer Cluster Partnering 2010 in
Oslo, from September 15th to 17th.
Oslo Cancer Cluster (Norway) welcome key players from the international
oncology community on September 15th to 17th, 2010. This event will showcase
Europe’s most promising oncology companies to leading network of investors,
bigpharma and industry executives in an effort to build partnerships, attract
investment and foster further business collaborations.
Fluofarma was exhibitor at the World Pharmaceutical Congress 2010 in
Philadelphia from June 15th to 17th.
Fluofarma was exhibitor at the AACR 101st Annual Meeting, April 17-21, 2010 in
Washington, DC.
Fluofarma was present at the 7th annual Screening Europe conference, in
Barcelona from February 11th to 12th, 2010.
Screening Europe is the largest screening event in Europe with four
conference rooms and international speakers. Fluofarma was exhibitor at this
conference.
Fluofarma was present at BELTOX-INVITROM congress in Edegem (Belgium), on November 25th. INVITROM and BELTOX will jointly organise this congress entitled: "Liver Toxicity: from in vitro to man".
Fluofarma participated at SMi's Cell-Based Assays conference, in London from
November 18th to 19th. The SMI's Cell-Based Assays conference is a high-level
meeting which brings together all the specialists of cellular assays.
Fluofarma was sponsor and exhibitor at the conference.
Fluofarma will be attending the International Contract Services Exhibition
2009 in Madrid, from October 13rd to 15th. ICSE is co-located with the world's
largest pharmaceutical networking event, CPhI worldwide, which brings together
key players to drive innovation and advancement in the industry.
Fluofarma will be exhibitor during ICSE 2009, please feel free to come
at our booth #8G11, we will be glad to present you our latest innovations and
services.
Fluofarma will be attending the CPhI Worldwide 2009 in Madrid, from October
13rd to 15th.
CPhI is as an international Convention on Pharmaceutical Ingredients and
intermediates. More than 125 countries, 25000 delegates and 1430 companies
will participate to CPhI 2009.Three sister events, ICSE, P-MEC and BioPh now
run alongside CPhI, a quadripartite of events that is considered the must
attend event for any individual or organisation within the pharmaceutical
manufacturing community.
Fluofarma will be attending the Drug Discovery 2009 in Liverpool, from
September 7th to 8th.
The ELRIG (European Laboratory and Robotics Interest Group) and BPS
(British Pharmacological Society) welcome key players from the drug discovery
community to Liverpool on September 7th and 8th, 2009.
Fluofarma will be attending the European Cancer Cluster Partnering 2009 in
Toulouse, from September 3rd to 4th.
The Toulouse Cancer-Bio-Santé Cluster (France) and Oslo Cancer Cluster
(Norway) welcome key players from the international oncology community to
Toulouse on September 3rd and 4th, 2009. This event will showcase Europe’s
most promising oncology companies to leading network of investors, bigpharma
and industry executives in an effort to build partnerships, attract investment
and foster further business collaborations.
Fluofarma will be attending the International Conference on Medicinal
Chemistry, in Orléans, from July 1st to 3rd 2009.
The University of Orleans and the Institute of Organic and Analytical Chemistry (ICOA) organize the 45th edition of the prestigious International Conference on Medicinal Chemistry (RICT 45). The scientific program is focused on drug discovery and selection. Various major and fascinating topics, going from biological, bio-physical and computing tools, through screening and organic synthesis to the discovery of new treatments, are proposed.
Fluofarma was present at the Society for Biomolecular Sciences 15th annual conference, in Lille, from April 26th to 30th. The SBS conference is an international event dedicated to the drug discovery strategies. Fluofarma was exhibitor during SBS conference 2009.
Fluofarma was present and exhibitor at Global Discovery & Development Innovation Forum, in London from March 2nd to 3rd. The GDDI forum is an international event dedicated to the drug discovery and development.
Fluofarma was present at Futurallia 2008, in Quebec, from May 20th to 23th.
Futurallia is an annual International Forum with two days of high-level
meetings in a warm and inviting atmosphere. Futurallia Quebec 2008 welcomed
more than 1200 participants from 20 countries. It represented 9 000 business
meetings.
Fluofarma participated at BioSquare 2008, in Basel, from March 12th to 14th.
Dr Mahfoudi, Fluofarma's business development manager, presented our
latest services especially in the cosmetics and predictive toxicity fields.